Licensable university IP
Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors is marketed for licensing by University of California. It is documented in US patent US 11,261,231. The current assignee of record is Altor Bioscience LLC. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2028-10-27.
The patent's current assignee of record differs from the marketing institution (University of California). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 11,261,231 | High | Google Patents |
| Patent title | Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors | High | Google Patents |
| Current assignee | Altor Bioscience LLC | Good | Google Patents |
| Original assignee | Altor Bioscience LLC | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2016-07-13 | High | Google Patents |
| Priority date | 2007-10-26 | High | Google Patents |
| Publication date | 2022-03-01 | High | Google Patents |
| Expected expiration | 2028-10-27 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 11,261,231 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Grouped under Biotechnology & Life Sciences · Materials & Chemistry · Mechanical & Industrial, derived from its patent classification (CPC A61P, C07K, C12N, G01N; Google Patents).
Original listing
This technology is marketed for licensing by University of California. View the original listing.